Chemoinformaics analysis of 10-bromo-7-hydroxy-11-iodolaurene
Molecular Weight | 421.116 | nRot | 1 |
Heavy Atom Molecular Weight | 402.972 | nRig | 12 |
Exact Molecular Weight | 419.959 | nRing | 2 |
Solubility: LogS | -5.917 | nHRing | 0 |
Solubility: LogP | 5.088 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 46.2543 |
nHD | 1 | BPOL | 23.1177 |
QED | 0.482 |
Synth | 4.164 |
Natural Product Likeliness | 1.519 |
NR-PPAR-gamma | 0.955 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.234 |
Pgp-sub | 0 |
HIA | 0.086 |
CACO-2 | -4.692 |
MDCK | 0.0000194 |
BBB | 0.631 |
PPB | 0.986651 |
VDSS | 3.443 |
FU | 0.0215668 |
CYP1A2-inh | 0.921 |
CYP1A2-sub | 0.898 |
CYP2c19-inh | 0.565 |
CYP2c19-sub | 0.768 |
CYP2c9-inh | 0.583 |
CYP2c9-sub | 0.837 |
CYP2d6-inh | 0.601 |
CYP2d6-sub | 0.902 |
CYP3a4-inh | 0.469 |
CYP3a4-sub | 0.474 |
CL | 5.732 |
T12 | 0.136 |
hERG | 0.009 |
Ames | 0.02 |
ROA | 0.47 |
SkinSen | 0.536 |
Carcinogencity | 0.064 |
EI | 0.92 |
Respiratory | 0.922 |
NR-Aromatase | 0.455 |
Antiviral | Yes |
Prediction | 0.653014 |